Earth Science Tech Shareholders Back Reverse Split and Series B Retirement in Bid for National Exchange Listing

Earth Science Tech shareholders approved key proposals that could lead to a Nasdaq or NYSE uplisting, including a reverse stock split and the retirement of Series B Preferred Stock, signaling a major strategic shift for the OTC-traded healthcare company.

AI Industry News Staff
••Business
Earth Science Tech Shareholders Back Reverse Split and Series B Retirement in Bid for National Exchange Listing

Earth Science Tech Inc. (OTC: ETST) took a significant step toward a potential national exchange listing after shareholders approved several key proposals at the company’s first Annual Meeting of Stockholders, held virtually on August 31, 2026. The approvals, which include a reverse stock split authorization and the retirement of the Series B Preferred Stock, could fundamentally reshape the company’s capital structure and governance, clearing a path for an uplisting to Nasdaq or the New York Stock Exchange.

Shareholders authorized the Board of Directors to execute a reverse stock split if necessary to meet the minimum bid price requirements for a national exchange listing. The authorization is valid for 12 months, giving the Board flexibility to act when market conditions are favorable. The move is critical because OTC-traded stocks often fail to meet the stringent listing standards of major exchanges, and a reverse split can help elevate the share price to required levels. CEO and Chairman Giorgio R. Saumat emphasized that he will not support a split that unduly disadvantages current shareholders, though the final decision rests with the Board.

In a more transformative vote, stockholders empowered the Board’s Independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This retirement would eliminate the company’s dual-class voting structure, a governance feature that often deters institutional investors and can complicate an exchange listing. By moving to a single class of common stock, Earth Science Tech would align its governance with the standards expected by Nasdaq and NYSE, potentially broadening its investor base and improving liquidity.

Additional proposals ratified at the meeting included the re-election of seven director nominees, the appointment of Semple, Marchal & Cooper LLP as an independent registered public accounting firm, and a new non-dilutive executive compensation framework. The compensation structure is designed to incentivize management without issuing additional shares, preserving shareholder value while motivating leadership to achieve the company’s strategic goals.

The implications of these approvals extend beyond mere compliance. If the company successfully uplists, it could gain access to a larger pool of institutional capital, increase its visibility in the investment community, and enhance its credibility with partners in the healthcare, pharmacy, and telemedicine sectors. Earth Science Tech operates as a strategic holding company in these high-growth industries, and an uplisting could provide the resources needed to expand its portfolio and accelerate innovation.

For shareholders, the decisions represent a vote of confidence in management’s long-term vision. The retirement of the Series B Preferred Stock, in particular, addresses a long-standing governance concern and could lead to a more equitable distribution of voting power. The reverse split, while often viewed with skepticism, is positioned as a strategic tool rather than a sign of distress, given the company’s stated goal of meeting exchange listing criteria.

Investors can find the latest news and updates relating to ETST in the company’s newsroom at https://ibn.fm/ETST. The full details of the meeting and the proposals are available in the company’s press release at https://ibn.fm/HIqJ9.

The coming months will be pivotal as the Board evaluates the timing of a reverse split and negotiates the retirement of the Series B Preferred Stock. Success could mark a new chapter for Earth Science Tech, transitioning it from the OTC market to a national exchange and positioning it for sustained growth in the competitive healthcare and telemedicine landscape.

Blockchain Registration

QR Code for Blockchain Registration